Introduction: To demonstrate, with the aid of retinal imaging, an abnormal post-operative macular appearance caused by the presence of a “fragmented” pre-retinal bubble of octafluoropropane (C3F8) masquerading as retained subretinal perfluorocarbon liquid (PFCL). Methods: This is an interventional case presentation. Results: Colour fundus photography high-resolution spectral domain-optical coherence tomography (SD-OCT) and clinical progress demonstrate that the abnormal reflex was caused by the presence of a small fragment of C3F8 becoming lodged at the pre-foveal area. Conclusion: Submacular entrapment of various substances used during vitrectomy has been described in a number of case reports and case series. To our knowledge, this is the first described case of a retained fragment of fluorocarbon gas trapped at the macula following successful retinal detachment repair and highlights a previously unreported cause of an abnormal foveal appearance. However, clinical examination together with the use of SD-OCT is helpful in differentiating the appearance from that seen in other retained vitrectomy adjuncts.

Although first described in 1973 [1], expansile gases are now commonly used during primary retinal detachment repair, and longer-acting tamponade agents such as octafluoropropane (C3F8) can be used in the treatment of giant retinal tear-associated retinal detachment when the macula is still preserved [2]. Perfluorocarbon liquid (PFCL) represents a significant adjunct in the treatment of the aforementioned type of retinal detachment and although its intraoperative role is important, several intra- and post-operative complications associated with its use have been reported in the literature [3]. These include post-operative PFCL retention, retinal slippage, and toxicity [4].

We herein demonstrate, with the aid of retinal imaging, an abnormal post-operative macular appearance caused by the presence of a “fragmented” pre-retinal bubble of C3F8 masquerading as retained subretinal PFCL.

A 60-year-old man presented to our institution with a right macula-off rhegmatogenous retinal detachment caused by a temporal giant retinal tear. Visual acuity was hand movements in the affected eye. He underwent a three-port 23-gauge pars plana vitrectomy with the use of PFCL and an endolaser, followed by 12% C3F8 gas for intraocular tamponade. Six weeks post-operatively, his vision was 6/60 and the retina was attached with a 20% C3F8 residual gas fill. An abnormal foveal reflex was seen with a bubble visible at the fovea (Fig. 1). Based on clinical examination, previously published literature about various substances trapped subretinally during vitrectomy, and the surgery adjuncts, it was assumed that this bubble consisted of trapped PFCL. The infra-red image (Fig. 2a) demonstrated a very distinct hyporeflectant lesion at the fovea. A cross-sectional spectral domain-optical coherence tomography (SD-OCT) scan through the centre of this point revealed a full-thickness macular hole along with shadowing at the level of the choroid (Fig. 2b). This shadow is probably caused by side-scatter of the light when it meets the surface of a foreign body present anterior to the macular hole. While subretinal PFCL has a distinct appearance, this bubble was not subretinal, thus making the differentiation difficult between a gas bubble or PFCL trapped in the margin of a macular hole.

Fig. 1.

a Colour fundus photograph of the right eye at the first post-operative review demonstrating a well-defined yellow foveal appearance with a bubble of retained C3F8. b Magnified image of the macula focusing anteriorly on the bubble itself (arrow). Notice that the bubble is trapped at the superior edge of the macular hole.

Fig. 1.

a Colour fundus photograph of the right eye at the first post-operative review demonstrating a well-defined yellow foveal appearance with a bubble of retained C3F8. b Magnified image of the macula focusing anteriorly on the bubble itself (arrow). Notice that the bubble is trapped at the superior edge of the macular hole.

Close modal
Fig. 2.

Images at the 6-week post-operative review. a Infra-red image showing a hyporeflective foveal spot. b Cross-sectional SD-OCT through the fovea showing a full thickness macular hole. In addition, there is shadowing at the level of the choroid (red arrow) caused by the pre-retinal bubble of C3F8. c 12 weeks afetr RD repair showing absorption of the gas bubble and normal appearance of Bruch’s membrane and choroidal layers.

Fig. 2.

Images at the 6-week post-operative review. a Infra-red image showing a hyporeflective foveal spot. b Cross-sectional SD-OCT through the fovea showing a full thickness macular hole. In addition, there is shadowing at the level of the choroid (red arrow) caused by the pre-retinal bubble of C3F8. c 12 weeks afetr RD repair showing absorption of the gas bubble and normal appearance of Bruch’s membrane and choroidal layers.

Close modal

Six weeks later the remaining C3F8 in the vitreous cavity had disappeared, including the bubble at the posterior pole. Further SD-OCT imaging confirmed the absence of the hyporeflectant reflex at the fovea, allowing a normal choroidal appearance in the presence of the macular hole (Fig. 2c). At this time, complete fundus examination was possible, allowing examination of the inferior fundus for a displaced PFCL bubble. Such a finding was not observed, confirming that this initially clinically visible bubble could not have been PFCL. In addition to this, the patient did not report reappearing of the blurring in his vision when in a supine position. At this point, taking into consideration the substances used during surgery and the fact that the bubble was no longer present, it was concluded that it consisted of a C3F8 bubble. The patient subsequently underwent vitrectomy with internal limiting membrane peeling and injection of 12% C3F8 gas. Two weeks post-operatively, the macular hole was closed, and the patient’s vision improved to 6/24.

PFCL is widely used during complex retinal detachment repair associated with giant retinal tears, and retained PFCL is one of the most common complications of its use. When subfoveal PFCL is identified, surgical removal is recommended in view of its toxic effects on the retina [4]. OCT can be used for the imaging of the PFCL bubbles, demonstrating typical features such as retinal pigment epithelium disorganisation and disruption of the external limiting membrane [5].

Revising the published literature, there are reports of cases where other substances can be trapped subretinally during vitrectomy. Silicone oil particles resemble beads and are slightly mobile among subretinal strands by changing the eye position [6]. Triamcinolone granules gradually decrease over 2 weeks and resolve completely by 3 weeks, while on follow-up the retina appears successfully attached and no functional damage is observed, thus not necessitating any surgical intervention [7].

In our case the foveal bubble observed post-operatively was initially mistaken for retained subretinal PFCL. However, further careful examination together with SD-OCT imaging and along with the clinical progress of the finding clearly confirmed this was in fact a fragment of C3F8 lodged at the posterior pole.

Macular hole formation following retinal detachment surgery is not uncommon [8] and can be successfully closed following further surgery. In this case we do not believe the bubble of gas at the macula contributed to macular hole formation, given that there was no suspicion over expansion of the trapped gas bubble, for example due to changes of altitude or use of nitrogen monoxide during general anaesthesia. On the other hand, it is likely the macular hole allowed this phenomenon to become visible.

To our knowledge, this is the first described case of a retained fragment of fluorocarbon gas at the macula following successful retinal detachment repair and highlights a previously unreported cause of an abnormal foveal appearance. We believe the small bubble of gas became anchored in place by the edges of the macula hole, thus allowing the gas bubble to bridge over it. Clinical examination together with the use of SD-OCT is helpful in differentiating the appearance from that seen in retained PFCL, silicone oil, or triamcinolone.

Compliance with ethical standards.

The authors have no conflict of interest to declare. None of the authors has any proprietary interest related to this paper.

No grant support or research funding was received by any of the authors.

1.
Norton
EW
.
Intraocular gas in the management of selected retinal detachments
.
Trans Am Acad Ophthalmol Otolaryngol
.
1973
Mar-Apr
;
77
(
2
):
OP85
98
.
[PubMed]
0002-7154
2.
Hoffman
ME
,
Sorr
EM
.
Management of giant retinal tears without scleral buckling
.
Retina
.
1986
;
6
(
4
):
197
204
.
[PubMed]
0275-004X
3.
Scott
IU
,
Murray
TG
,
Flynn
HW
 Jr
,
Feuer
WJ
,
Schiffman
JC
;
Perfluoron Study Group
.
Outcomes and complications associated with giant retinal tear management using perfluoro-n-octane
.
Ophthalmology
.
2002
Oct
;
109
(
10
):
1828
33
.
[PubMed]
0161-6420
4.
Shulman
M
,
Sepah
YJ
,
Chang
S
,
Abrams
GW
,
Do
DV
,
Nguyen
QD
.
Management of retained subretinal perfluorocarbon liquid
.
Ophthalmic Surg Lasers Imaging Retina
.
2013
Nov
;
44
(
6
):
577
83
.
[PubMed]
2325-8160
5.
Soheilian
M
,
Nourinia
R
,
Shoeibi
N
,
Peyman
GA
.
Three-Dimensional OCT Features of Perfluorocarbon Liquid Trapped Under the Fovea
.
Ophthalmic Surg Lasers Imaging
.
2010
Mar
;
•••
:
1
4
.
[PubMed]
1542-8877
6.
Honda
Y
,
Ueno
S
,
Miura
M
,
Yamaguchi
H
.
Silicone oil particles trapped in the subretinal space: complications after substitution of the vitreous
.
Ophthalmologica
.
1986
;
192
(
1
):
1
5
.
[PubMed]
0030-3755
7.
Sampangi
R
,
Venkatesh
P
,
Garg
SP
.
Natural history of sub-retinal triamcinolone acetonide deposition after triamcinolone-assisted vitrectomy
.
Int Ophthalmol
.
2008
Oct
;
28
(
5
):
359
62
.
[PubMed]
0165-5701
8.
Garcia-Arumi
J
,
Boixadera
A
,
Martinez-Castillo
V
,
Zapata
MA
,
Fonollosa
A
,
Corcostegui
B
.
Macular holes after rhegmatogenous retinal detachment repair: surgical management and functional outcome
.
Retina
.
2011
Oct
;
31
(
9
):
1777
82
.
[PubMed]
0275-004X
Open Access License / Drug Dosage / Disclaimer
This article is licensed under the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC). Usage and distribution for commercial purposes requires written permission. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.